Transforming growth factor-β in myocardial disease

NG Frangogiannis - Nature Reviews Cardiology, 2022 - nature.com
Transforming growth factor-β (TGFβ) isoforms are upregulated and activated in myocardial
diseases and have an important role in cardiac repair and remodelling, regulating the …

Antitumor mechanisms of molecules secreted by Trypanosoma cruzi in colon and breast cancer: A review

S Sadr, S Ghiassi, N Lotfalizadeh… - Anti-Cancer Agents …, 2023 - ingentaconnect.com
Background: Molecules secreted by Trypanosoma cruzi (T. cruzi) have beneficial effects on
the immune system and can fight against cancer by inhibiting the growth of tumor cells …

Mechanisms behind the high mortality rate in chronic Chagas cardiomyopathy: Unmasking a three‐headed monster

LE Echeverría, AY Serrano‐García… - European Journal of …, 2024 - Wiley Online Library
Chagas disease is a neglected tropical disease caused by the parasite Trypanosoma cruzi.
Chronic Chagas cardiomyopathy (CCC), the most severe form of target organ involvement in …

Molecular and clinical aspects of chronic manifestations in Chagas disease: a state-of-the-art review

GJ Medina-Rincón, S Gallo-Bernal, PA Jiménez… - Pathogens, 2021 - mdpi.com
Chronic manifestations of Chagas disease present as disabling and life-threatening
conditions affecting mainly the cardiovascular and gastrointestinal systems. Although …

Perspectives for a new drug candidate for Chagas disease therapy

MNC Soeiro - Memorias do Instituto Oswaldo Cruz, 2022 - SciELO Brasil
Chagas disease (CD), a neglected tropical illness caused by the protozoan Trypanosoma
cruzi, affects more than 6 million people mostly in poor areas of Latin America. CD has two …

[HTML][HTML] Exercise-based training programs for patients with chronic Chagas cardiomyopathy: A systematic review and meta-analysis

PM Calderon-Ramirez, D Fernandez-Guzman… - IJC Heart & …, 2023 - Elsevier
Background We assessed the effects of exercise-based training programs (EBTP) in patients
with chronic Chagas cardiomyopathy (CCC) through a systematic review and meta-analysis …

Statins change the cytokine profile in Trypanosoma cruzi-infected U937 macrophages and murine cardiac tissue through Rho-associated kinases inhibition

F González-Herrera, NS Clayton… - Frontiers in …, 2023 - frontiersin.org
Introduction Chronic Chagasic cardiomyopathy (CCC), caused by the protozoan
Trypanosoma cruzi, is the most severe manifestation of Chagas disease. CCC is …

[HTML][HTML] Introducing the NUATEI Consortium: A Mexican Research Program for the Identification of Natural and Synthetic Antimicrobial Compounds for Prevalent …

JC Carrero, B Espinoza, L Huerta, M Silva-Miranda… - Pharmaceuticals, 2024 - mdpi.com
The need for new drugs to treat human infections is a global health concern. Diseases like
tuberculosis, trypanosomiasis, amoebiasis, and AIDS remain significant problems …

Regulatory impact of statins on macrophage polarization: mechanistic and therapeutic implications

M Sadeghi, S Khayati, S Dehnavi… - Journal of Pharmacy …, 2024 - academic.oup.com
Statins, also known as HMG-CoA reductase inhibitors, are widely prescribed drugs for the
prevention and treatment of cardiovascular diseases. In addition to their lipid-lowering …

Chagas heart disease: beyond a single complication, from asymptomatic disease to heart failure

IG Montalvo-Ocotoxtle, G Rojas-Velasco… - Journal of Clinical …, 2022 - mdpi.com
Chagas cardiomyopathy (CC), caused by the protozoan Trypanosoma cruzi, is an important
cause of cardiovascular morbidity and mortality in developing countries. It is estimated that 6 …